CEO, RNA Therapeutics Startup: Lead Gene Therapy Breakthroughs

NLC Health Ventures

Nijmegen

Hybride

EUR 90 000 - 150 000

Plein temps

Il y a 10 jours

Une candidature complète en une minute

Un CV et une lettre de motivation personnalisés, prêts à envoyer.

Passez les filtres ATS

Avantages offerts par ce poste

Equity-based compensation
Modest base salary until fundraising

Résumé du poste

XtRNA Bio, a pioneering biotechnology venture, seeks a Founder/CEO to steer research toward clinical development and fundraising. You will unite scientific insight with strategic execution, building a high-performing team and forming partnerships to propel the tRNA platform forward.

The role requires Europe-based leadership with travel to Nijmegen and equity-based compensation. The CEO will shape strategy, lead fundraising, and represent the company to investors and partners, driving

Qualifications

  • Proven experience leading or scaling biotech or pharmaceutical ventures.
  • Strong fundraising and partnership development track record.
  • Ability to unite scientific vision with business strategy and execution.

Responsabilités

  • Lead the company’s overall strategy, growth, and fundraising efforts, securing seed and Series A investment.
  • Drive the scientific and clinical roadmap toward IND readiness for the CMT2D program, while expanding the tRNA platform.
  • Build and inspire a multidisciplinary team combining scientific excellence with entrepreneurial focus.
  • Establish strong partnerships with investors, academic collaborators, pharmaceutical partners, and patient foundations.
  • Represent XtRNA Bio externally, communicating vision, progress, and potential to biotech and investment communities.

Connaissances

Fundraising
Strategic partnerships
Leadership
Strategy development
Business development

Formation

PhD or MD in Life Sciences
MBA or equivalent (advantage)

Description du poste

XtRNA Bio, a pioneering biotechnology venture, seeks a Founder/CEO to steer research toward clinical development and fundraising. You will unite scientific insight with strategic execution, building a high-performing team and forming partnerships to propel the tRNA platform forward.

The role requires Europe-based leadership with travel to Nijmegen and equity-based compensation. The CEO will shape strategy, lead fundraising, and represent the company to investors and partners, driving

Obtenez votre examen gratuit et confidentiel de votre CV.

ou faites glisser et déposez votre fichier ici.

Similar jobs

Postes similaires à comparer

CEO (Gene Therapy) XtRNA
CEO (Gene Therapy) XtRNA

NLC Health Ventures • Nijmegen

Hybride
EUR 90 000 - 150 000
Equity-based compensation
Modest base salary until fundraising
CEO (Gene Therapy) XtRNA
CEO (Gene Therapy) XtRNA

NLC- The Healthtech Venture Builder • Nijmegen

Sur place
EUR 120 000 - 180 000
Equity-based compensation
Modest base salary until fundraising
Scientist | RNA Biology & Neuromuscular Gene Therapy
Scientist | RNA Biology & Neuromuscular Gene Therapy

NLC- The Healthtech Venture Builder • Nijmegen

Sur place
EUR 50 000 - 55 000
On-site Nijmegen
Startup culture
RNA Biology Scientist - Neuromuscular Gene Therapy
RNA Biology Scientist - Neuromuscular Gene Therapy

NLC- The Healthtech Venture Builder • Nijmegen

Sur place
EUR 50 000 - 55 000
On-site Nijmegen
Startup culture
Scientist – RNA Biology & Neuromuscular Gene Therapy (AAV)
Scientist – RNA Biology & Neuromuscular Gene Therapy (AAV)

CAREERS AT NLC • Nijmegen

Sur place
EUR 50 000 - 55 000
Scientist | RNA Biology & Neuromuscular Gene Therapy
Scientist | RNA Biology & Neuromuscular Gene Therapy

CAREERS AT NLC • Nijmegen

Sur place
EUR 50 000 - 55 000
RNA Therapeutics Study Physician | Medical Director
RNA Therapeutics Study Physician | Medical Director

ProQR Therapeutics N.V. • Pays-Bas

Sur place
EUR 120 000 - 180 000
Annual performance bonus
Stock options
Pension plan
+3
Director, Toxicology — Translational RNA Therapeutics Leader
Director, Toxicology — Translational RNA Therapeutics Leader

ProQR Therapeutics N.V. • Pays-Bas

À distance
EUR 150 000 - 190 000
Annual bonus
Stock options
Pension plan
+3
RNA Therapeutics Design Lead - siRNA & Computational Design
RNA Therapeutics Design Lead - siRNA & Computational Design

Grünenthal Group • Breukelen

Hybride
EUR 110 000 - 160 000
Director Toxicology
Director Toxicology

ProQR Therapeutics N.V. • Pays-Bas

Sur place
EUR 150 000 - 190 000
Annual bonus
Stock options
Pension plan
+3